Nukkleus Operating Cycle from 2010 to 2026

NUKK Stock  USD 2.25  0.22  8.91%   
Nukkleus Operating Cycle yearly trend continues to be quite stable with very little volatility. The value of Operating Cycle is projected to decrease to 2.36. From the period between 2010 and 2026, Nukkleus, Operating Cycle regression line of its data series had standard deviation of  21.95 and standard deviation of  21.95. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
2.49
Current Value
2.36
Quarterly Volatility
21.94558744
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 K, Selling General Administrative of 10.4 M or Selling And Marketing Expenses of 48.6 K, as well as many indicators such as Price To Sales Ratio of 0.74, Dividend Yield of 6.0E-4 or Days Sales Outstanding of 2.36. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
Build AI portfolio with Nukkleus Stock
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
Historical Operating Cycle data for Nukkleus serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Nukkleus represents a compelling investment opportunity.

Latest Nukkleus' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Nukkleus over the last few years. It is Nukkleus' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nukkleus' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Very volatile
   Operating Cycle   
       Timeline  

Nukkleus Operating Cycle Regression Statistics

Arithmetic Mean20.23
Geometric Mean9.61
Coefficient Of Variation108.48
Mean Deviation19.95
Median4.56
Standard Deviation21.95
Sample Variance481.61
Range48.4759
R-Value0.06
Mean Square Error511.75
R-Squared0
Significance0.81
Slope0.27
Total Sum of Squares7,706

Nukkleus Operating Cycle History

2026 2.36
2025 2.49
2023 2.16
2022 37.77
2021 16.39
2016 50.64

About Nukkleus Financial Statements

Nukkleus investors utilize fundamental indicators, such as Operating Cycle, to predict how Nukkleus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 2.49  2.36 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. Anticipated expansion of Nukkleus directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nukkleus assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(4.93)
Revenue Per Share
3.422
Quarterly Revenue Growth
(0.95)
Return On Assets
(3.97)
Return On Equity
(7.42)
Investors evaluate Nukkleus using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nukkleus' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nukkleus' market price to deviate significantly from intrinsic value.
It's important to distinguish between Nukkleus' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nukkleus should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nukkleus' market price signifies the transaction level at which participants voluntarily complete trades.